ACOD1 and glioblastoma: In summary, despite scRNA‐seq analyses conducted in one biological replicate per experimental condition represent a limitation of the study, we here elucidated the diversity of the myeloid compartment along GBM progression and under ACOD1 deficiency by corroborating the main findings by flow cytometry, immunohistological and targeted gene expression analyses.